Devices for delivering a controlled concentration of an agent are provided. The device includes a reservoir for the agent and a flow control portion operably connected to the reservoir. The device also includes a valve for releasing the agent from the flow control portion and a pump for flowing air to mix with the agent released by the valve and for flowing the agent and air mixture out of the device. Methods of delivering a vaporized agent to a subject are also provided. The methods include storing a liquid agent in a reservoir of a device and flowing the agent into a flow control chamber to change the agent to a gas. The methods also include mixing the agent in gas form with air and flowing the agent and air mixture out of the device to be delivered to a subject.

Devices for delivering a controlled concentration of an agent are provided. The device includes a reservoir for the agent and a flow control portion operably connected to the reservoir. The device also includes a valve for releasing the agent from the flow control portion and a pump for flowing air to mix with the agent released by the valve and for flowing the agent and air mixture out of the device. Methods of delivering a vaporized agent to a subject are also provided. The methods include storing a liquid agent in a reservoir of a device and flowing the agent into a flow control chamber to change the agent to a gas. The methods also include mixing the agent in gas form with air and flowing the agent and air mixture out of the device to be delivered to a subject.

The present technology relates to systems and/or methods for enabling a respiratory device to be configured when a clinician or healthcare professional is remote from the respiratory device. One form provides a method of configuring a respiratory device, the respiratory device comprising a processor configured to control operation of the respiratory device in accordance with a plurality of operating parameters. The method comprises determining a combination of settings for the device from an identifier sent to the device, the identifier corresponding to the combination of settings, and configuring the respiratory device accordingly. Another form provides a method of verifying the configuration of the respiratory device by outputting an identifier corresponding to the combination of settings for the device, and determining the settings from the identifier.

The present technology relates to systems and/or methods for enabling a respiratory device to be configured when a clinician or healthcare professional is remote from the respiratory device. One form provides a method of configuring a respiratory device, the respiratory device comprising a processor configured to control operation of the respiratory device in accordance with a plurality of operating parameters. The method comprises determining a combination of settings for the device from an identifier sent to the device, the identifier corresponding to the combination of settings, and configuring the respiratory device accordingly. Another form provides a method of verifying the configuration of the respiratory device by outputting an identifier corresponding to the combination of settings for the device, and determining the settings from the identifier.

Disclosed is a cartridge for storing pressurized gas, including a main body with an internal volume for storing a gaseous mixture NO/N.sub.2, and a distribution valve for controlling the output of the gas. The internal volume of the main body is less than 1000 ml. The concentration of NO in the gaseous mixture NO/N.sub.2 is between 15000 and 25000 ppmv. The gas pressure in the internal volume is below 15 bar, measured at 23° C. Installation for delivering gas to a patient, including such a gas cartridge, a NO supply device fed by the gas cartridge, and a medical ventilator feeding a patient circuit which has an inhalation branch fed by the NO supply device. Use for treating patients suffering from pulmonary hypertension or hypoxia.

Disclosed is a cartridge for storing pressurized gas, including a main body with an internal volume for storing a gaseous mixture NO/N.sub.2, and a distribution valve for controlling the output of the gas. The internal volume of the main body is less than 1000 ml. The concentration of NO in the gaseous mixture NO/N.sub.2 is between 15000 and 25000 ppmv. The gas pressure in the internal volume is below 15 bar, measured at 23° C. Installation for delivering gas to a patient, including such a gas cartridge, a NO supply device fed by the gas cartridge, and a medical ventilator feeding a patient circuit which has an inhalation branch fed by the NO supply device. Use for treating patients suffering from pulmonary hypertension or hypoxia.

Alveolar dead space of a subject is determined by measuring an end tidal partial pressure of carbon dioxide during a sequence of normal breaths of the subject and, during a sequence of deep breaths by the subject, delivering a first volume of a first gas to the subject over a first portion of each inspiration by the subject. The first volume is less than or equal to an expected alveolar volume of the subject when the subject is breathing normally. A second volume of a second gas is delivered to the subject over a second portion of each inspiration. The second gas includes a neutral gas. An end tidal partial pressure of carbon dioxide is measured during the sequence of deep breaths. The alveolar dead space is computed using the end tidal partial pressures of carbon dioxide measured during the sequence of normal breaths and the sequence of deep breaths.

Systems, methods and apparatuses for aerosolizing all or substantially all plant matter, medications, flavors, smells, liquid and/or other material to be aerosolizing are disclosed. Embodiments of the invention comprise an aerosolization chamber sealed except for two or more conduits, a first conduit coupled to a source of fully or almost fully oxygenated gas, a heating element capable of heating the aerosolization chamber to a temperature above a combustion temperature, a second conduit configured to transport aerosolized gases and elements out of the chamber and, in one implementation, at least one valve positioned in the second conduit preventing the flow of atmospheric air into the vaporization chamber. In some instances, the first gas substantially clears the vaporization chamber of atmospheric air prior to reaching combustion temperature. A second gas containing oxygen may be intermixed with the vaporization gases and vaporized elements proximal to the combustion chamber.

Systems, methods and apparatuses for aerosolizing all or substantially all plant matter, medications, flavors, smells, liquid and/or other material to be aerosolizing are disclosed. Embodiments of the invention comprise an aerosolization chamber sealed except for two or more conduits, a first conduit coupled to a source of fully or almost fully oxygenated gas, a heating element capable of heating the aerosolization chamber to a temperature above a combustion temperature, a second conduit configured to transport aerosolized gases and elements out of the chamber and, in one implementation, at least one valve positioned in the second conduit preventing the flow of atmospheric air into the vaporization chamber. In some instances, the first gas substantially clears the vaporization chamber of atmospheric air prior to reaching combustion temperature. A second gas containing oxygen may be intermixed with the vaporization gases and vaporized elements proximal to the combustion chamber.

The present invention provides new devices, systems, and methods for delivering enriched oxygen to recipients (e.g., chronically ill patients, such as COPD patients). One aspect is a more efficient portable oxygen concentrator that is configured to deliver an enriched oxygen airflow having a significantly lower overall oxygen concentration and greater overall volume administered as compared to currently marketed or known portable oxygen concentrators. Administering the lower oxygen concentration at higher volumes allows for the present portable oxygen concentrators to deliver an equivalent number of moles of oxygen as administered by traditional portable concentrators while increasing the efficiency of the system and the ability of the system to maintain the therapeutic level of oxygen concentration for a longer period.